{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:37:43Z","timestamp":1783381063869,"version":"3.54.6"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajog.2021.11.1367","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T20:38:08Z","timestamp":1644871088000},"page":"S945-S953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S","title":["Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8234-025X","authenticated-orcid":false,"given":"Scott W.","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Jerome F.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.11.1367_bib1","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0015-0282(02)02976-X","article-title":"Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle","volume":"77","author":"Veenstra van Nieuwenhoven","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.11.1367_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000009973","article-title":"Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy","volume":"45","author":"Lurie","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2021.11.1367_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines--chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.11.1367_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.HYP.0000130483.83154.37","article-title":"Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia","volume":"44","author":"Leik","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.11.1367_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10641950801958067","article-title":"Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia","volume":"27","author":"Cadden","year":"2008","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2021.11.1367_bib6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/HYPERTENSIONAHA.111.176602","article-title":"Mechanisms of enhanced vascular reactivity in preeclampsia","volume":"58","author":"Mishra","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.11.1367_bib7","doi-asserted-by":"crossref","first-page":"48.e1","DOI":"10.1016\/j.ajog.2006.08.038","article-title":"Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia","volume":"196","author":"Shah","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mob.2001.117311","article-title":"Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia","volume":"185","author":"Gervasi","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"Sacks","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/HYPERTENSIONAHA.111.188730","article-title":"Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia","volume":"59","author":"Mousa","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.11.1367_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1933719114557899","article-title":"Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia","volume":"22","author":"Shukla","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2021.11.1367_bib12","first-page":"227","article-title":"Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for the generation of lipid peroxides in the circulation","volume":"72","author":"G\u00f6r\u00f6g","year":"1991","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ajog.2005.01.057","article-title":"Neutrophils from pregnant women produce thromboxane and tumor necrosis factor-alpha in response to linoleic acid and oxidative stress","volume":"193","author":"Vaughan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib14","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ajog.2006.02.053","article-title":"Thromboxane mediates neutrophil superoxide production in pregnancy","volume":"195","author":"Vaughan","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1096\/fasebj.14.10.1289","article-title":"Placental isoprostane is significantly increased in preeclampsia","volume":"14","author":"Walsh","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2021.11.1367_bib16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/0002-9378(93)90419-J","article-title":"Secretion of lipid peroxides by the human placenta","volume":"169","author":"Walsh","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib17","first-page":"1888","article-title":"Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia","volume":"80","author":"Walsh","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.11.1367_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10641959609015693","article-title":"Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia","volume":"15","author":"Walsh","year":"1996","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2021.11.1367_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/hy0102.100778","article-title":"Activation of leukocytes during the uteroplacental passage in preeclampsia","volume":"39","author":"Mellembakken","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.11.1367_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10641959409084168","article-title":"Lipid peroxidation in pregnancy","volume":"13","author":"Walsh","year":"1994","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2021.11.1367_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-1016256","article-title":"Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia","volume":"16","author":"Walsh","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2021.11.1367_bib23","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2021.11.1367_bib24","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1210\/jcem.87.8.8727","article-title":"Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies","volume":"87","author":"Wang","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.11.1367_bib25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib26","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2174\/1381612033453884","article-title":"Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases","volume":"9","author":"Ahn","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajog.2021.11.1367_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cell.2009.02.018","article-title":"Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site","volume":"137","author":"Trivedi","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ajog.2021.11.1367_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1165\/rcmb.2005-0109OC","article-title":"Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells","volume":"33","author":"Suzuki","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0037-1616227","article-title":"Protease-activated receptors in vascular biology","volume":"86","author":"Coughlin","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2021.11.1367_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","article-title":"Rocks: multifunctional kinases in cell behaviour","volume":"4","author":"Riento","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/0975-3583.74258","article-title":"The role of RhoA\/Rho kinase pathway in endothelial dysfunction","volume":"1","author":"Yao","year":"2010","journal-title":"J\u00a0Cardiovasc Dis Res"},{"key":"10.1016\/j.ajog.2021.11.1367_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajpath.2010.11.003","article-title":"Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction","volume":"178","author":"Estrada-Gutierrez","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib33","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s43032-020-00232-4","article-title":"Proteases activate pregnancy neutrophils by a protease-activated receptor 1 pathway: epigenetic implications for preeclampsia","volume":"27","author":"Walsh","year":"2020","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2021.11.1367_bib34","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1159\/000373979","article-title":"Activation of PAR-1\/NADPH oxidase\/ROS signaling pathways is crucial for the thrombin-induced sFlt-1 production in extravillous trophoblasts: possible involvement in the pathogenesis of preeclampsia","volume":"35","author":"Huang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ajog.2021.11.1367_bib35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.fertnstert.2012.06.038","article-title":"Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia","volume":"98","author":"Zhao","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.11.1367_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14767050802034859","article-title":"Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation","volume":"21","author":"Erez","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.11.1367_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/path.1338","article-title":"The pattern of expression of protease-activated receptors (PARs) during early trophoblast development","volume":"200","author":"Even-Ram","year":"2003","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib38","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2353\/ajpath.2007.060465","article-title":"Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia","volume":"170","author":"Lockwood","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","article-title":"Eicosanoids in preeclampsia","volume":"70","author":"Walsh","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.ajog.2021.11.1367_bib40","first-page":"22","article-title":"The road to low-dose aspirin therapy for the prevention of preeclampsia began with the placenta","author":"Walsh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2021.11.1367_bib41","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s43032-020-00234-2","article-title":"Placental production of eicosanoids and sphingolipids in women who developed preeclampsia on low-dose aspirin","volume":"27","author":"Walsh","year":"2020","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2021.11.1367_bib42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1210\/jcem-68-3-676","article-title":"Thromboxane and prostacyclin production by different compartments of the human placental villus","volume":"68","author":"Nelson","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.11.1367_bib43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/0002-9378(88)90560-1","article-title":"Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries","volume":"159","author":"Thorp","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/10641959809006076","article-title":"Maternal perfusion with low-dose aspirin preferentially inhibits placental thromboxane while sparing prostacyclin","volume":"17","author":"Walsh","year":"1998","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2021.11.1367_bib45","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0002-9378(89)90932-0","article-title":"Aspirin differentially affects thromboxane and prostacyclin production by trophoblast and villous core compartments of human placental villi","volume":"161","author":"Nelson","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0891-5849(94)00157-F","article-title":"Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas","volume":"18","author":"Wang","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajog.2021.11.1367_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(95)02072-1","article-title":"The isoprostanes. Current knowledge and directions for future research","volume":"51","author":"Morrow","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib48","first-page":"219","article-title":"The isoprostanes: novel markers of lipid peroxidation and potential mediators of oxidant injury","volume":"23","author":"Roberts","year":"1995","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1016\/j.ajog.2021.11.1367_bib49","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A\u00a0series of prostaglandin F2-like compounds are produced in\u00a0vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2021.11.1367_bib50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.59.6.612","article-title":"PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH","volume":"59","author":"Kukreja","year":"1986","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2021.11.1367_bib51","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0002-9378(12)80013-5","article-title":"Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women","volume":"167","author":"Walsh","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1933719110361960","article-title":"Neutrophil expression of cyclooxygenase 2 in preeclampsia","volume":"17","author":"Bachawaty","year":"2010","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2021.11.1367_bib53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/1933719115607998","article-title":"Matrix metalloproteinase 1 causes vasoconstriction and enhances vessel reactivity to angiotensin II via protease-activated receptor 1","volume":"23","author":"Nugent","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2021.11.1367_bib54","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1161\/01.ATV.17.12.3519","article-title":"Thrombin-induced thromboxane synthesis by human platelets. Properties of anion binding exosite I-independent receptor","volume":"17","author":"Henriksen","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-09-355958","article-title":"Matrix metalloproteases and PAR1 activation","volume":"121","author":"Austin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2021.11.1367_bib56","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.RES.0000033520.95242.A2","article-title":"Galpha(q) and Gbetagamma regulate PAR-1 signaling of thrombin-induced NF-kappaB activation and ICAM-1 transcription in endothelial cells","volume":"91","author":"Rahman","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2021.11.1367_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0031-6997(24)01493-5","article-title":"Proteinase-activated receptors","volume":"53","author":"Macfarlane","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ajog.2021.11.1367_bib58","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1158\/0008-5472.CAN-05-3897","article-title":"Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation","volume":"66","author":"Goerge","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2021.11.1367_bib59","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jsgi.2006.06.001","article-title":"Systemic activation and vascular infiltration of neutrophils with term labor","volume":"13","author":"Leik","year":"2006","journal-title":"J\u00a0Soc Gynecol Investig"},{"key":"10.1016\/j.ajog.2021.11.1367_bib60","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.11.1367_bib61","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40265-014-0252-2","article-title":"Vorapaxar: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ajog.2021.11.1367_bib62","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(12)61269-0","article-title":"Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2\u00b0P-TIMI 50 trial","volume":"380","author":"Scirica","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.11.1367_bib63","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(76)93026-9","article-title":"Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy","volume":"1","author":"Shapiro","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.11.1367_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(78)91367-3","article-title":"Aspirin for the treatment of recurrent toxaemia","volume":"2","author":"Goodlin","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.11.1367_bib65","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.11.1367_bib66","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0002-9378(99)70661-7","article-title":"Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta","volume":"180","author":"Nelson","year":"1999","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821026272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821026272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:37:06Z","timestamp":1757590626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821026272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002937821026272"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.11.1367","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.11.1367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}